Endocrine oncology

Eliciting Low-Risk Thyroid Cancer Treatment Preferences Using Clinical Vignettes: A Pilot Study

Endocr PractPublished Pilot study

Authors' conclusion

When treatments for low-risk thyroid cancer are described clearly and accurately through clinical vignettes, patients may be more likely to choose less invasive treatment options over traditional surgical resection.

Study context

Population
Thyroid cancer survivors and general population volunteers ranking vignettes on small (≤1 cm) differentiated thyroid cancer treatment10 survivors, 9 general population
Participants
19 participants
Comparison
Patient preference rankings of active surveillance (AS), radiofrequency ablation (RFA), TL and total thyroidectomy (TT) for low-risk thyroid cancer
Outcome
Preference ranking of clinical vignettes
Methodological detailsclinical vignettes, preference ranking, formative qualitative methods, Vignettes content validated via interviews with 5 academic subspecialists
  • Clinical vignettes
  • Preference ranking
  • Formative qualitative methods
  • Vignettes content validated via interviews with 5 academic subspecialists

Main finding

As reported in the abstract

Median ranking among uncomplicated vignettes

AS

1

median

RFA

2

median

TL

3.5

median

TT

5

median

AS vs RFA: P = 0.02 · AS vs TT: P < 0.01 · TL vs TT: P < 0.01

Further findings

Complicated vignettes ranked lower than uncomplicated counterparts

Cases with complications ranked lower (excellent comprehension)
99.0%

Survivors vs general population

Trends were consistent between thyroid cancer survivors and the general population

Original publication

Eliciting Low-Risk Thyroid Cancer Treatment Preferences Using Clinical Vignettes: A Pilot Study. Endocr Pract. Published 29 April 2023. doi:10.1016/j.eprac.2023.04.008

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.